Project Grant SB1DK107094

This Project Grant award of $278,224 from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research program) supports the development of a novel, noninvasive "Burst Wave Lithotripsy" (BWL) technology to fragment larger kidney stones. The goal is to expand on prior successful testing of BWL for 10 mm stones to address the 10-20 mm stone range, while addressing key technical challenges around...

Federal Grant Award Summary Maguro Surgical Inc. received a $610,736 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 15, 2025, through August 31, 2026. The award supports the development and refinement of the MagStone system, a novel magnetic-based medical device designed to improve the endoscopic retrieval of kidney stone...

Federal Grant Award Summary Vivifi Medical, Inc. received a $650,000 Phase I Small Business Innovation Research (SBIR) award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 15, 2025, through August 31, 2026. The company is developing a novel procedural approach and medical device technology to treat benign prostatic hyperplasia (BPH), a condition...

The National Science Foundation awarded $256,000 to Optave Diagnostics LLC through the Technology, Innovation, and Partnerships program (CFDA 47.084) to develop a prototype endoscopic probe for molecular imaging and diagnosis of cancerous prostate pathologies. The 12-month project grant will support the creation of a medical device using photoacoustic imaging and acoustic lens technology to aid in the detection and diagnosis of prostate cancer. The proposed endoscopic probe offers an alternative...

Alsus Medical Inc. received a $255,564 Project Grant award from the National Science Foundation under the Small Business Innovation Research (SBIR) program (CFDA 47.084) to develop a minimally invasive transurethral cryotherapy catheter system for benign prostate hyperplasia. The SBIR program funds the critical early stages of research and development for technologies with strong potential to meet federal research and development needs and transition to commercial applications. Under this...

Grant Award Summary 3VO Medical, Inc. received a $304,452 Small Business Innovation Research (SBIR) Phase I Project Grant from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) awarded June 1, 2025, with completion targeted for May 31, 2026. The company is developing an intrauterine labor augmentation system (ILAS)—a minimally invasive, trans-birth-canal medical device designed to augment Stage I active labor by providing direct fluidic...

The National Science Foundation (NSF) awarded a $305,000 Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant to Cicadea Biotech LLC, a women-owned small business, to develop a novel, non-invasive urine test for early detection of kidney cancer. The goal of this 17-month project is to demonstrate the specificity and accuracy of a biomarker to detect kidney tumors at an early stage, before symptoms appear, as well as its effectiveness in detecting residual disease in kidney cancer...

Crystal Sonic Inc. received a $275,000 Small Business Innovation Research Phase I project grant from the National Science Foundation under the Technology, Innovation, and Partnerships program (CFDA 47.084). The grant supported the development of a new approach to lower the cost of advanced semiconductor manufacturing through the use of acoustic energy to precisely cut and lift off thin semiconductor devices from their host substrates without waste. By enabling substrate reuse, this "Sonic...

This Project Grant awarded by the National Cancer Institute (NCI), under the federal Cancer Detection and Diagnosis Research program (CFDA 93.394), provides $399,789 to Ergami Endoscopy, Inc. to develop an automated robotic flexible overtube device capable of blind insertion during colonoscopy procedures. The device aims to reduce physician injuries, improve productivity, and decrease patient pain/sedation requirements for the over 16 million colonoscopies performed annually in the U.S. Key...

Teliatry Inc. received a $768,138 project grant award from the National Institutes of Health's National Institute of Biomedical Imaging and Bioengineering to develop a minimally invasive, single incision, rechargeable spinal cord stimulation system for chronic pain management. The grant was awarded under the Discovery and Applied Research for Technological Innovations to Improve Human Health program. Through this award, Teliatry will engineer the world's smallest (0.75cc), most cost-effective...